Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
The EMBO Journal|September 16, 1998
Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genesJ Schwaller, J Frantsve, J Aster, et al.
Blood|June 15, 1996
Linkage of a familial platelet disorder with a propensity to develop myeloid malignancies to human chromosome 21q22.1-22.2C Y Ho, B Otterud, R D Legare, et al.
Leukemia|February 20, 2004
Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemiasP Vandenberghe, I Wlodarska, L Michaux, et al.
Blood|December 1, 1996
TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemiaT W McLean, S Ringold, D Neuberg, et al.
Blood Cancer Journal|July 26, 2012
Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasmsK L Rice, X Lin, K Wolniak, et al.
Molecular Cell|October 13, 2000
Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2J Schwaller, E Parganas, D Wang, et al.
Leukemia|May 29, 2010
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosisA Tefferi, T L Lasho, O Abdel-Wahab, et al.
Leukemia|April 24, 2009
Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogeneticsS Heinrichs, R V Kulkarni, C E Bueso-Ramos, et al.
Leukemia|March 6, 2009
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosisA Tefferi, A Pardanani, K-H Lim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 1997
High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomesC Wheeler, C Eickhoff, A Elias, et al.
Pageof 13